Login

VIDEO / RINCONADA: El convenio con la empresa Lipigas permitirá mejorar el acceso al gas en la zona. 00:10:00

Share On Facebook Share On Twitter

Angel Solimano is the CEO of Empresas Lipigas.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Integrity Partners with Lion Street to Expand Life and Wealth Solutions
00:10:00
Focused startups LaunchDarkly and Sourcegraph, which both raised at multi-billion-dollar valuations|Scott Raney,Director,Redpoint
00:10:00
Understanding Emerging Markets: Opportunities, Trends, and Strategic Investments | Jan van Eck, CEO , VanEck .
00:10:00
G Mining Ventures Will Mine Gold in 2024 Using a Proven Track Record of Mine Building Success | Louis-Pierre Gignac, CEO, G-MINING Sarl (IE)
00:10:00
DRIVING SUSTAINABLE SOLUTIONS FOR BRAZIL’S ENERGY SECTOR|Marcelo Eduardo Martins,Vice-Chairman AT Cosan
00:10:00
Leapfrogging offers a strategic advantage by bypassing traditional developmental stages to adopt newer, more advanced technologies or practices, yielding faster progress and competitive edge.
00:10:00
Next Demba Sow from Alsace France pitched Hodi Hodi|Vincent Diallo,Founder & General Partner,Interlace Ventures
00:10:00
David Discusses Dark Horse Resources' Focus on Gold and Lithium in Argentina
00:10:00
Demystifying Securitized Fixed Income: Opportunities and Strategies for Investors | John Kerschner, CFA - Head of US Securitised Products | Portfolio Manager of Janus Henderson Investors
00:10:00
William "Bill" Nuti, CEO of NCR Corp., discusses the company's third-quarter performance.|Michael D. Hayford Retiring as NCR Chief Executive Officer
00:10:00
Can You Negotiate Auto Insurance Rates? Tips for Lowering Premiums
00:10:00
"Boaz Weinstein on the Power of Closed-End Fund Arbitrage | Bloomberg Invest 2024"

© 2017 - Neuhu+